Back to Journals » Cancer Management and Research » Volume 12

High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab

Total article views   HTML views PDF downloads Totals
6,837 Dovepress* 6,396+ 1,002 7,398
PubMed Central* 441 206 647
Totals 6,837 1,208 8,045
*Since 21 January 2020

View citations on PubMed Central and Google Scholar